The National Times - Meta shares jump on strong earnings report

Meta shares jump on strong earnings report


Meta shares jump on strong earnings report
Meta shares jump on strong earnings report / Photo: © AFP/File

Meta on Wednesday reported quarterly earnings that topped market expectations, as revenue grew along with investments in artificial intelligence.

Change text size:

The parent of Facebook and Instagram said it made a profit of $22.8 billion on revenue of nearly $60 billion in the recently ended quarter, adding it could take in as much as $56.5 billion in the current quarter.

"We had strong business performance in 2025," Meta co-founder and chief executive Mark Zuckerberg said in an earnings release.

Meta shares rose more than 10 percent in after-market trades.

Some 3.58 billion people used apps owned by Meta daily in the quarter, according to the social networking giant.

Meanwhile costs tallied $35.15 billion, an increase of 40 percent from the same period a year earlier, the earnings reported noted.

Capital expenses, including infrastructure such as data centers to power AI, were $22.14 billion in the quarter, according to the company.

Meta added that it anticipates capital expenditures in the $115 billion to $135 billion range this fiscal year, driven by increased investment in Meta Superintelligence Labs and its core business.

"I'm looking forward to advancing personal superintelligence for people around the world in 2026," Zuckerberg said.

- Smart glasses v. phones -

Zuckerberg has predicted that AI-infused smart glasses will be the "next major computing platform," eventually replacing the smartphone.

But Reality Labs -- Meta's virtual and augmented reality unit -- has consistently posted big losses.

Meta is locked in a bitter rivalry with other tech behemoths racing to invest heavily in AI, aiming to ensure the technology benefits society and generates profits in the not-so-distant future.

Most analysts believe Meta will make the investment pay off by improving advertising efficiency and creating new opportunities, such as with its smart glasses through a partnership with Ray-Ban maker EssilorLuxottica.

The earnings report came as a landmark trial accusing Meta of being among tech firms addicting young people to social media gets underway in Los Angeles.

The case being heard in California state court is being called a "bellwether" proceeding because its outcome could set the tone for a tidal wave of similar litigation across the United States.

Snap and TikTok-parent ByteDance have negotiated settlements to avoid the trial, leaving Meta and Alphabet's YouTube as the remaining defendants.

Zuckerberg is slated to be called as a witness during the trial.

The case focuses on allegations that a 19-year-old woman identified by the initials K.G.M. suffered severe mental harm because she was addicted to social media.

Social media firms are accused in hundreds of lawsuits of addicting young users to content that has led to depression, eating disorders, psychiatric hospitalization and even suicide.

Internet titans have argued that they are shielded by Section 230 of the US Communications Decency Act, which frees them of responsibility for what social media users post.

However, this case argues those firms are culpable for business models designed to hold people's attention and to promote content that winds up harming their mental health.

Meta and YouTube have rejected the allegations.

H.Davies--TNT

Featured

Carney touts Canada 'pivot' away from US as Trump levels new threat

Canadian Prime Minister Mark Carney said Tuesday that reducing economic ties with the United States would come at a cost but the benefits were clear, as President Donald Trump threatened new penalties targeting Canada.

Nearly 1,100 flights cancelled after UK air traffic control glitch

Almost 1,100 flights to and from UK airports were cancelled Tuesday due to what the country's air traffic control service called a technical issue, in the latest glitch to spark travel chaos.

Carney touts Canada 'pivot' away from US as tariffs rise

Canadian Prime Minister Mark Carney on Tuesday said reducing economic ties with the United States would come at a cost but the long-term benefits were clear, as retaliatory tariffs on US products took effect.

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Change text size: